 Connection
Alyssa Schlenz to Stroke
This is a "connection" page, showing publications Alyssa Schlenz has written about Stroke.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.609 |
|
|
|
-
Schlenz AM, Phillips SM, Mueller M, Humphrey D, Stevens J, Williams LP, Nickel RS, Dolatshahi L, Miller RE, Hulbert ML, Lee MT, Alvarez O, Fuh B, McNaull MA, Bhasin N, Melvin CL, Adams RJ, Kanter J. Successful implementation of stroke risk screening for sickle cell anemia in the DISPLACE study: results of a cluster randomized trial. Implement Sci. 2025 11 26; 20(1):50.
Score: 0.489
-
Schlenz AM, Phillips SM, Stevens J, Williams LP, Lee MT, Nickel R, Fuh B, Dolatshahi L, Kanter J. Lessons Learned From Provider Minder: A Provider Tracking Application for Improving Stroke Risk Screening in Sickle Cell Anemia. Qual Manag Health Care. 2026 Apr-Jun 01; 35(2):110-118.
Score: 0.482
-
Schlenz AM, Phillips SM, Dumas J, Kanter J. Development and Process Evaluation of Sickle Stroke Screen: A Patient Educational Initiative to Improve Transcranial Doppler Screening in Sickle Cell Anemia. J Pediatr Hematol Oncol Nurs. 2025 Jan-Feb; 42(1-2):5-18.
Score: 0.469
-
Schlenz AM, Phillips S, Mueller M, Melvin C, Adams RJ, Kanter J. Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium. Pediatr Blood Cancer. 2020 04; 67(4):e28172.
Score: 0.325
-
Schlenz AM, Hayes J, Mueller M, Phillips S, Adams RJ, Kanter J. Incomplete implementation of guideline-based stroke prevention therapy in sickle cell disease. Am J Hematol. 2018 09; 93(9):E222-E224.
Score: 0.295
-
Bills SE, Schatz J, Gillooly E, Johnston JD, Waters AL, Schlenz AM. Academic and cerebrovascular outcomes after neurodevelopmental screening in sickle cell disease: A longitudinal cohort study. Dev Med Child Neurol. 2026 07; 68(7):916-924.
Score: 0.122
-
Edwards JG, Humphrey DT, Mueller M, Phillips S, Schlenz A, Oni MO, Kanter J, Bona K, Archer NM. Socioeconomic Status and Stroke Risk in Pediatric Sickle Cell Disease: A DISPLACE Study Secondary Analysis. Pediatr Blood Cancer. 2026 Jan; 73(1):e32112.
Score: 0.121
-
Davidow KA, Miller RE, Phillips SM, Schlenz AM, Mueller M, Hulbert ML, Hsu LL, Bhasin N, Adams RJ, Kanter J. DISPLACE study shows poor quality of transcranial doppler ultrasound for stroke risk screening in sickle cell anemia. Blood Adv. 2024 07 09; 8(13):3444-3452.
Score: 0.111
-
Fraley CE, Neiman JS, Feddersen CR, James C, Jones TG, Mikkelsen M, Nuss R, Schlenz AM, Winters AC, Green AL, Compas BE. Identifying patterns of neurocognitive dysfunction through direct comparison of children with leukemia, central nervous system tumors, and sickle cell disease. Pediatr Blood Cancer. 2023 06; 70(6):e30299.
Score: 0.102
-
Kanter J, Phillips S, Schlenz AM, Mueller M, Dooley M, Sirline L, Nickel R, Brown RC, Hilliard L, Melvin CL, Adams RJ. Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1062-e1068.
Score: 0.092
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|